Pergolide therapy in parkinson's disease
β
P. Jeanty; M. Kerchove; A. Lowenthal; H. Bruyne
π
Article
π
1984
π
Springer
π
English
β 543 KB
A total of 26 patients were treated with pergolide mesylate, a semi-synthetic ergot derivative with the property of direct dopamine activity. Of these patients, 18 suffered from late failure of L-dopa, while the remaining 8 had never before been treated with L-dopa. The aim of the trial was to study